Dr. Todd McAllister, Ph.D. - Chairman
Dr. McAllister received his Ph.D. in BioMedical Engineering from the University of California, San Diego. He is the co-founder and CEO of Cytograft Tissue Engineering, Inc. Dr. McAllister has been an early proponent of biological approaches to tissue engineering that do not require synthetic scaffolds. Dr. McAllister has also pioneered a novel business strategy within Regenerative Medicine, taking Cytograft’s lead product, the Lifeline™ Vascular Graft from inception to commercial licensure in Europe on less than $10M in private equity.
Dr. McAllister also served as Co-Director of the Center for Regenerative Medicine at the St. Joseph’s Translational Research Institute in Atlanta, where he oversaw a broader range of cell-based cardiovascular repair technologies. He also serves on several advisory boards, including Lumen, Biocardia, and the Medical University of South Carolina.
Dr. Nicolas L'Heureux, Ph.D.
Dr. L’Heureux received his Ph.D. in Cell Biology from Laval University in Quebec, Canada and was a post-doctoral AHA fellow in the
Department of Bioengineering at the University of California, San Diego. He is the co-founder and CSO of Cytograft Tissue Engineering, Inc. Dr. L'Heureux invented Tissue Engineering by Self-Assembly (TESA), a novel tissue engineering strategy. He advocates a biological approach to Regenerative Medicine, minimizing the inclusion of synthetic scaffolds and exogenous biomaterials.
Dr. L'Heureux also served as Co-Director of the Center for Regenerative Medicine at the St. Joseph’s Translational Research Institute in Atlanta. As a co-director he oversaw research of cell-based cardiovascular repair technologies.
Dr. Robert J. Robbins, MD.
Dr. Robert C. Robbins is the president and CEO of the Texas Medical Center. He attended the University of Mississippi Medical Center where he received his MD and completed his general surgical training. He completed his Cardiothoracic Surgery Residency at Stanford University.
In addition to his work at Texas Medical Center, Dr. Robbins is also a manuscript reviewer for a number of prestigious journals including the New England Journal of Medicine, Annals of Thoracic Surgery, and the Journal of Thoracic and Cardiovascular Surgery. He also serves on the editorial board of the Journal of Thoracic and Cardiovascular Surgery, Cardiac Surgery Digest, the Journal of Heart and Lung Transplantation, and Innovations.
Jose M. Malbran
Jose Malbran has extensive experience in the private banking industry with significant regional exposure throughout Latin America, Europe, the Middle East and Africa. He has spent more than 30 years at Merrill Lynch in successive Private Client senior management roles including the Chairman of the the International Private Client Group.
Over the last 20 years, Mr. Malbran's leadership has fostered productivity and profitability. He has served as District Director for Southern Latin America, giving him the responsibility of overseeing the International Private Client business in Panama, Caracas, Sao Paulo, Montevideo, Santiago (Chile), as well as ML Banque Suisse in Montevideo. He has also served as chairman of International Private Client Group Latin America and became a member of the Executive Committee. Additionally, he held the position of Chairman of Merrill Lynch International Banks and participated in several investment banking deals, debt offerings and privatizations. He has also held the positions of Senior Vice President and member of the GPC Executive Committee, as well as Director of Merrill Lynch Cayman Bank and Trust Company.
As Director for the Stanford Hospital Corporate Partners Program, Ted seeks to enhance strategic relationships with corporations, venture capitalist and entrepreneurs that generate financial resources, opportunities and alliances for Stanford University Medical Center. These relationships seek to accelerate the translation of technology solutions for improve patient care delivery, research processes and innovative medical education.
Ted led the University of Chicago’s Corporate Relations and New Initiatives efforts for the Graduate School of Business. In this role he initiated the development of the school’s global strategy and established partnerships and degree granting programs in Asia through strategic industry alliances and with the Monetary Authority of Singapore and Economic Development Board.
Ted is also an adviser, investor and board member for various early-stage technology ventures initiatives. He is a member of the Board of Directors of BioCardia-- http://www.biocardia.com/ Ted was a founder and board member of Ibrix, Inc, a rapidly scalable parallel computing file system available for cluster computing, grid computing, and enterprise computing environments (acquired by HP, Aug. '09).